Graham Rushton

1.5k total citations
21 papers, 1.2k citations indexed

About

Graham Rushton is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Graham Rushton has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cell Biology and 4 papers in Immunology and Allergy. Recurrent topics in Graham Rushton's work include Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (6 papers) and Fibroblast Growth Factor Research (6 papers). Graham Rushton is often cited by papers focused on Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (6 papers) and Fibroblast Growth Factor Research (6 papers). Graham Rushton collaborates with scholars based in United Kingdom, Netherlands and Slovakia. Graham Rushton's co-authors include John T. Gallagher, Malcolm Lyon, Seth L. Schor, Ana M. Schor, Claire L. Cole, Gordon C. Jayson, Egle Avizienyte, John M. Gardiner, Ann Marie Grey and Steen U. Hansen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Graham Rushton

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graham Rushton United Kingdom	17	718	607	181	146	138	21	1.2k
Silvia Goldoni United States	16	947 1.3×	813 1.3×	238 1.3×	205 1.4×	96 0.7×	24	1.8k
Rabia Sadir France	22	695 1.0×	652 1.1×	399 2.2×	217 1.5×	72 0.5×	28	1.3k
Sylvain D. Vallet France	14	547 0.8×	347 0.6×	130 0.7×	137 0.9×	96 0.7×	19	1.1k
Liu Cao Canada	20	570 0.8×	657 1.1×	135 0.7×	301 2.1×	80 0.6×	31	1.2k
C M Svahn United States	12	1.2k 1.6×	954 1.6×	113 0.6×	129 0.9×	101 0.7×	13	1.5k
Carl M. Svahn United States	10	864 1.2×	689 1.1×	79 0.4×	123 0.8×	88 0.6×	11	1.2k
Orit Goldshmidt Israel	16	822 1.1×	875 1.4×	90 0.5×	86 0.6×	76 0.6×	21	1.2k
E Schönherr Germany	14	537 0.7×	657 1.1×	63 0.3×	168 1.2×	111 0.8×	20	1.1k
Joji Iida United States	21	781 1.1×	594 1.0×	288 1.6×	362 2.5×	54 0.4×	32	1.5k
Jo Ann Buczek‐Thomas United States	17	407 0.6×	332 0.5×	55 0.3×	130 0.9×	92 0.7×	31	791

Countries citing papers authored by Graham Rushton

Since Specialization

Citations

This map shows the geographic impact of Graham Rushton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Rushton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Rushton more than expected).

Fields of papers citing papers by Graham Rushton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Rushton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Rushton. The network helps show where Graham Rushton may publish in the future.

Co-authorship network of co-authors of Graham Rushton

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Rushton. A scholar is included among the top collaborators of Graham Rushton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Rushton. Graham Rushton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Avizienyte, Egle, Claire L. Cole, Graham Rushton, et al.. (2016). Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo. PLoS ONE. 11(8). e0159739–e0159739. 9 indexed citations

2.

Jayson, Gordon C., Steen U. Hansen, Gavin J. Miller, et al.. (2015). Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology. Chemical Communications. 51(72). 13846–13849. 39 indexed citations

3.

Cole, Claire L., Graham Rushton, Gordon C. Jayson, & Egle Avizienyte. (2014). Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor (EGF)-like Growth Factor/EGF Receptor Signaling. Journal of Biological Chemistry. 289(15). 10488–10501. 51 indexed citations

4.

Hansen, Steen U., Gavin J. Miller, Claire L. Cole, et al.. (2013). Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies. Nature Communications. 4(1). 2016–2016. 49 indexed citations

5.

Miller, Gavin J., Steen U. Hansen, Egle Avizienyte, et al.. (2013). Efficient chemical synthesis of heparin-like octa-, deca- and dodecasaccharides and inhibition of FGF2- and VEGF165-mediated endothelial cell functions. Chemical Science. 4(8). 3218–3218. 33 indexed citations

6.

Rushton, Graham, Claire L. Cole, Muhammad Babur, et al.. (2012). Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor. Journal of Biological Chemistry. 287(43). 36132–36146. 64 indexed citations

7.

Pickford, Claire E., Rebecca Holley, Graham Rushton, et al.. (2011). Specific Glycosaminoglycans Modulate Neural Specification of Mouse Embryonic Stem Cells. Stem Cells. 29(4). 629–640. 54 indexed citations

8.

Cole, Claire L., Steen U. Hansen, Marek Baráth, et al.. (2010). Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis. PLoS ONE. 5(7). e11644–e11644. 47 indexed citations

9.

Holley, Rebecca, Claire E. Pickford, Graham Rushton, et al.. (2010). Influencing Hematopoietic Differentiation of Mouse Embryonic Stem Cells using Soluble Heparin and Heparan Sulfate Saccharides. Journal of Biological Chemistry. 286(8). 6241–6252. 41 indexed citations

10.

Cole, Claire L., Alison Backen, Andrew R. Clamp, et al.. (2010). Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer. Cancer Biology & Therapy. 10(5). 495–504. 71 indexed citations

11.

Avizienyte, Egle, Claire L. Cole, Steen U. Hansen, et al.. (2010). Abstract 1374: Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. Cancer Research. 70(8_Supplement). 1374–1374. 8 indexed citations

12.

Johnson, Claire, Brett E. Crawford, Marios P. Stavridis, et al.. (2007). Essential Alterations of Heparan Sulfate During the Differentiation of Embryonic Stem Cells to Sox1-Enhanced Green Fluorescent Protein-Expressing Neural Progenitor Cells. Stem Cells. 25(8). 1913–1923. 108 indexed citations

13.

Johnson, Claire, Brett E. Crawford, Marios P. Stavridis, et al.. (2007). Essential Alterations of Heparan Sulfate During the Differentiation of Embryonic Stem Cells to Sox1-Enhanced Green Fluorescent Protein-Expressing Neural Progenitor Cells. Stem Cells. 25(9). 2389–2389. 8 indexed citations

14.

Lyon, Malcolm, Graham Rushton, Janet A. Askari, Martin J. Humphries, & John T. Gallagher. (2000). Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin. Journal of Biological Chemistry. 275(7). 4599–4606. 75 indexed citations

15.

Lyon, Malcolm, Graham Rushton, & John T. Gallagher. (1997). The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific. Journal of Biological Chemistry. 272(29). 18000–18006. 237 indexed citations

16.

Schofield, K. P., Graham Rushton, Martin J. Humphries, T. M. Dexter, & John T. Gallagher. (1997). Influence of Interleukin-3 and Other Growth Factors on α4β1 Integrin-Mediated Adhesion and Migration of Human Hematopoietic Progenitor Cells. Blood. 90(5). 1858–1866. 37 indexed citations

17.

Schor, Ana M., et al.. (1994). Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. International Journal of Cancer. 59(1). 25–32. 39 indexed citations

18.

Schor, Seth L., Ann Marie Grey, Ana M. Schor, et al.. (1991). Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): Implications for cancer pathogenesis. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 59. 127–146. 16 indexed citations

19.

Schor, Seth L., Ana M. Schor, & Graham Rushton. (1988). Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. Journal of Cell Science. 90(3). 401–407. 55 indexed citations

20.

Schor, Seth L., Ana M. Schor, Ann Marie Grey, & Graham Rushton. (1988). Foetal and cancer patient fibroblasts produce an autocrine migrationstimulating factor not made by normal adult cells. Journal of Cell Science. 90(3). 391–399. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact